论文部分内容阅读
选取我院2014年5月-2016年5月收治的40例反流性食管炎引起的慢性咳嗽患者,按照随机双盲的方式,分成观察组和对照组,各20例。观察组通过兰索拉唑胶囊、盐酸依托必利分散片和阿莫西林胶囊治疗,对照组给予兰索拉唑胶囊、盐酸依托必利分散片治疗,对比两组临床疗效。结果观察组和对照组的治疗总有效率分别为:95.00%、70.00%,组间比较,差异显著,差异具有统计学意义,P<0.05。结论反流性食管炎引起的慢性咳嗽通过兰索拉唑肠溶片等三联药治疗,临床效果较好,值得临床深入推广。
Forty patients with chronic cough caused by reflux esophagitis were selected from May 2014 to May 2016 in our hospital. Patients were divided into observation group and control group with 20 cases in each group according to a randomized double-blind method. The observation group was treated with lansoprazole capsules, hydrochloretase and hydrochloric acid tablets and amoxicillin capsules. The control group was treated with lansoprazole capsules and hydrochioride tablets. The clinical efficacy was compared between the two groups. Results The total effective rates of the observation group and the control group were 95.00% and 70.00%, respectively. There was significant difference between the two groups (P <0.05). Conclusion Reflux esophagitis caused by chronic cough by lansoprazole enteric-coated triple therapy, the clinical effect is better, it is worth clinical in-depth promotion.